ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers
Jul 12, 2023•14 min•Ep. 67
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week, we're hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We'll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we're hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We'll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.
For the best experience, listen in Metacast app for iOS or Android